Ambitious new 10-year life sciences vision for UK

The government has published a new UK Life Sciences Vision setting out a 10-year strategy. Using the sector’s remarkable successes during COVID-19 as a blueprint, it aims to speed up the delivery of innovations to patients.

Co-developed with industry experts and business leaders, the vision outlines seven key missions on which the government, industry, the NHS, universities and charities will collaborate to solve some of our generation’s biggest healthcare issues.

The missions are:

  • Accelerating research on new dementia treatments
  • Enabling earlier diagnosis and treatment of disease, including cancer vaccines and other immune therapies
  • Supporting British vaccine research, development and manufacturing
  • Treatment and prevention of cardiovascular disease
  • Reducing incidence of and deaths from respiratory disease in the UK and worldwide
  • Researching the biology of ageing
  • Improving understanding and treatment of mental illness, including redefining conditions

 

Britain’s life sciences sector has been at the heart of the battle against COVID-19, from the UK Vaccines Taskforce and the Oxford-AstraZeneca vaccine to the RECOVERY trial, a world-leading project to identify safe and effective medications.

The Vision aims to emulate these successes, cutting red tape and leveraging private expertise to solve challenges at speed and at risk. It will take full advantage of new regulatory freedoms offered by Brexit, and is the first sectoral publication that builds on the government’s Plan for Growth, which aims to “level up” the UK into a world-leading centre for innovation and jobs of the future.

The Vision aims to cultivate a UK business environment where life sciences companies can access the funding they need to grow and innovate, are regulated in an efficient and agile way, and are incentivised to make and sell their products in the UK.

The government is putting its money where its mouth is with the simultaneous launch of a new £200 million Life Sciences Investment Programme, which has increased funding available for promising UK life sciences companies to £1 billion.

The life sciences sector employs over 250,000 people and generates an £80 billion turnover  every year. One of the Vision’s key themes is supporting growth in the sector, attracting more investment and creating highly skilled jobs throughout the UK.

Recent Posts

Press A to Apply: Crafting Irresistible Job Offers in Gaming March 7, 2024

In the competitive gaming industry, attracting top talent can be as challenging as conquering a final-level boss. The demand for skilled professionals in game development, design, marketing, and other specialised fields has never been higher. To stand out in this crowded landscape, employers need to go beyond the ordinary and create irresistible job offers that not only entice candidates but also make them eager to press the metaphorical 'A' button and join your team.

Breaking Barriers: Diversity and Inclusion in Tech Recruitment February 28, 2024

In the fast-paced world of technology, diversity and inclusion have become imperative for fostering innovation, creativity, and sustainable growth. Breaking barriers in tech recruitment is not just a moral imperative but a strategic necessity for companies looking to thrive in the digital age. In this article, we explore the importance of diversity in the tech industry, ways companies can enhance the recruitment process to achieve greater inclusivity, and the role of recruitment agencies in building diverse tech teams.

Crafting the Future: Trends in Tech Engineering February 21, 2024

In the ever-evolving landscape of technology, staying ahead of the curve is not just a choice; it's a necessity. One of the trends that has been gaining significant traction is DevOps, a set of practices that combines software development and IT operations. The importance and business value of DevOps in today's tech-driven world cannot be overstated, and its role is only set to grow in the future.